Alan Ashworth - 29 Sep 2021 Form 3 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role: Director
Signature: /s/ Lloyd Rowland, as Attorney-in-Fact for Alan Ashworth
Issuer symbol: CTMX
Transactions as of: 29 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 07 Oct 2021, 17:11:50 UTC
Next filing: 17 Jun 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney